| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 08:00 - 08:30 | Registration | ||||||
| 08:30 - 08:40 | Opening Ceremony |
Fang-Ming Chen
|
|||||
| 08:40 - 09:00 | [Keynote Speech] Right Choice Beyond Survival: How Taiwan is Pioneering Quality and Equity in Breast Cancer Care Through Value-Based Reform |
Chung-Liang Shih
|
Ming-Feng Hou
|
||||
| 09:00 - 09:30 | Session(1) Early Onset Breast Cancer: Current Knowledge and Gaps |
Kyong Hwa Park
|
King-Jen Chang
|
||||
| 09:30 - 10:00 | Session (1) Role of Platinum in Adjuvant/Neoadjuvant Treatment in TNBC |
Joohyuk Sohn
|
Shyr-Ming Sheen-Chen
|
||||
| 10:00 - 10:40 | Session (1) Redefining the Role of TKIs in HER2-Positive mBC: From Systemic Control to CNS Penetration |
Nancy Lin
|
Tsu-Yi Chao
|
||||
| 10:40 - 11:00 | Coffee Break | ||||||
| 11:00 - 11:40 | Session (2) Navigating the Complexities of Treatment in HR+ HER2- Metastatic Breast Cancer: Tailoring CDK4/6 Inhibitors to Meet Individual Patient Needs |
Hope S. Rugo
|
Hsien-Tang Yeh
|
||||
| 11:40 - 12:20 | Session (2) The Practice of Treating HR+/HER2- Early Breast Cancer is Evolving: Boardening the Impact of CDK4/6 Inhibitors |
Peter Fasching
|
Fang-Ming Chen
|
||||
| 12:20 - 13:05 | Luncheon Symposium (1) Maximizing Treatment Benefit and Overall Survival in HER2- Negative MBC |
Hsu-Huan Chou
|
Dar-Ren Chen
|
||||
| 13:05 - 13:20 | Coffee Break | ||||||
| 13:20 - 14:00 | Session (2) The Sustainable Efficacy of CDK4/6 Inhibitor in HR+/Her2- Node+ High Risk Early Breast Cancer |
Michael Gnant
|
Shin-Cheh Chen
|
||||
| 14:00 - 14:30 | Session (2) Personalized Neo-Adjuvant Strategies for Hormone Receptor-Positive Early Breast Cancer |
Marc Thill
|
Shigehira Saji
|
||||
| 14:30 - 15:10 | Session (2) Choosing Wisely:TS-1 for HR+ EBC |
Kun-Ming Rau
|
Hsien-Kun Chang
|
||||
| 15:10 - 15:30 | Coffee Break | ||||||
| 15:30 - 16:10 | Session (2) Transforming Treatment Landscape of HR+ mBC: Integrating Genomic Biomarkers to Drive Precision Medicine |
Naoto T. Ueno
|
Chiun-Sheng Huang
|
||||
| 16:10 - 16:50 | Session (2) The Next Wave of Endocrine and Target Therapy for HR+/HER2- Metastatic Breast Cancer |
Peter Schmid
|
Ling-Ming Tseng
|
||||
| 16:50 - 17:30 | Session (3) Unlocking the Potential of ADC: Transforming Breast Cancer Outcomes Across HER2 Expression Spectrum (MBC) |
Naoto T. Ueno
|
Yen-Shen Lu
|
||||
| 17:30 - 18:00 | Session (3) Current Status and Emerging Approaches in HER2+ Metastatic Breast Cancer |
Giampaolo Bianchini
|
Ta-Chung Chao
|
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 10:10 - 10:30 | [TBCS-GBCC Joint Session] Axillary management following NAC: Surgical Oncologists’ point of views |
Jai Min Ryu
|
Guo-Shiou Liao
|
||||
| 10:30 - 10:50 | [TBCS-GBCC Joint Session] Axillary management following NAC: Medical Oncologists’ point of views |
Guo-Shiou Liao
|
|||||
| 10:50 - 11:10 | [TBCS-GBCC Joint Session] Axillary management following NAC: Radiation Oncologists’ point of views |
Tzu-Yu Lai
|
Guo-Shiou Liao
|
||||
| 11:10 - 11:30 | [TBCS-GBCC Joint Session] Wrap up: Current guidelines of Axillary management following NAC |
Judy C. Boughey
|
Guo-Shiou Liao
|
||||
| 11:30 - 12:00 | [TBCS-GBCC Joint Session] Axillary management following NAC: Surgical Oncologists’ point of views | ||||||
| 12:10 - 12:50 | Please Proceed to Room 701BC for the Lunch Symposium | ||||||
| 14:00 - 14:05 | [Young Doctors Forum] Opening |
Chi-Cheng Huang
|
|||||
| 14:05 - 14:30 | [Young Doctors Forum] Beyond the White Coat: Challenges Facing Young Female Breast Oncologists and How to Address Them |
Kelly Hunt
|
|||||
| 14:30 - 14:55 | [Young Doctors Forum] Global Perspectives: Navigating Career Pathways in Breast Cancer Treatment for Young Doctors |
Tristen Park
|
|||||
| 14:55 - 15:00 | [Young Doctors Forum] Q&A | ||||||
| 15:00 - 15:05 | Coffee Break | ||||||
| 15:05 - 16:30 | Young Doctors Debate | ||||||
| 15:45 - 16:25 | Young Doctors Debate | ||||||
| 16:25 - 16:30 | QA & Closing | ||||||
| 16:30 - 17:00 | Group Photo |
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 12:30 - 13:30 | Lunch & Coffee Break | ||||||
| 14:40 - 15:00 | Coffee Break |
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 11:10 - 11:50 | Let’s Meet the Master (1) Marc Thill | ||||||
| 13:30 - 14:10 | Let’s Meet the Master (2) Judy C. Boughey |
Wen-Ling Kuo
|
|||||
| 15:00 - 15:30 | Let’s Meet the Master (3) Giampaolo Bianchini |
Jiun-I Lai
|
|||||
| 16:10 - 16:50 | Let’s Meet the Master (4) Peter Fasching |
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 08:10 - 08:50 | Breakfast Symposium: Beyond Cancer-Related Fatigue: Exploring Immunomodulatory Strategies to Reshape Breast Cancer Care |
Ming-Shen Dai
|
Kun-Ming Rau
|
||||
| 08:50 - 09:20 | Session (4) The Surgeon's Role in Locoregional Management of Stage IV Breast Cancer |
Mehra Golshan
|
Takashi Ishikawa
|
||||
| 09:20 - 09:50 | Session (4) Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy |
Judy C. Boughey
|
Jyh-Cherng Yu
|
||||
| 09:50 - 10:05 | Coffee Break | ||||||
| 10:05 - 10:35 | Session (4) Omission of Radiation Therapy Post Breast Conserving Surgery |
Boon Chua
|
Shou-Tung Chen
|
||||
| 10:35 - 11:05 | Session (4) Setting the Standard for the Future of Cancer Surgery |
Kelly Hunt
|
Fiona Tsui-Fen Cheng
|
||||
| 11:05 - 11:45 | Session (5) Shifting Paradigms in mTNBC - Advancing Sacituzumab Towards the Frontline |
Sherene Loi
|
Chin-Yao Lin
|
||||
| 11:45 - 12:25 | Session (5) A New Era in the Treatment of Metastatic Triple-Negative Breast Cancer: Who, When, and Why to Use Immunotherapy and Antibody-Drug Conjugates |
Sung Bae Kim
|
Chun-Yu Liu
|
||||
| 12:25 - 13:10 | Luncheon Symposium (2) Advances in Dual HER2 Inhibition: Shaping the Future of HER2-Positive Breast Cancer Care |
Chih-Chiang Hung
|
Ming-Yang Wang
|
||||
| 13:10 - 13:30 | Coffee Break | ||||||
| 13:30 - 14:10 | Session (6) Breaking the Ceiling: Strategies to Reduce Recurrence in HER2+ Early Breast Cancer |
Chi-Cheng Huang
|
Yuan-Ching Chang
|
||||
| 14:10 - 14:50 | Session (6) HER2+ Breast Cancer in the Era of Biosimilars: Optimizing Access with Herzuma |
Ching-Ting Wei
|
Chao-Ming Hung
|
||||
| 14:50 - 15:05 | Coffee Break | ||||||
| 15:05 - 15:45 | Session (6) Optimizing HER2 Management Among Breast Cancer Patients: Role of Trastuzumab in Evolving Therapeutic Paradigms |
Wen-Hung Kuo
|
|||||
| 15:45 - 16:25 | Session (6) From Evidence to Action: Impact of Xgeva in Breast Cancer Bone Metastasis |
I-Chen Tsai
Chao-Ming Hung
|
Kuo-Ting Lee
|
||||
| 16:25 - 16:45 | Award Ceremony | ||||||
| 16:45 - 17:00 | Closing |
Yen-Shen Lu
|
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 09:35 - 10:15 | TBD |
Chih-Hao Huang
|
Chih-Chiang Hung
|
||||
| 10:15 - 10:55 | New Horizons in First-Line Management of HR+ mBC with PIK3CA Mutation |
Shih-Che Shen
|
|||||
| 10:55 - 11:35 | Immunotherapy in Early TNBC: Evolving Evidence, Maximizing Benefit Through Thoughtful Patient Selection |
Han-Fang Cheng
|
Ling-Ming Tseng
|
||||
| 11:35 - 12:15 | Suture Scaffold Technique in Breast-Conserving Surgery: Safety, Cosmetic Outcomes, and Lessons from Over 2,000 Cases |
Reiko Mitsueda
|
Chen-Hsiang Chang
|
||||
| 12:15 - 13:10 | Luncheon Symposium Treatment Strategies and Sequencing After ET + CDK4/6i for Patients With ER+/HER2- Metastatic Breast Cancer |
Soo Chin Lee
|
Wei-Pang Chung
|
||||
| 13:10 - 13:50 | Not all CDK4/6i are created equal: Optimizing HR+ HER2- Metastatic Breast Cancer Treatment Outcomes |
Michael Gnant
|
Ching-Hung Lin
|
||||
| 13:50 - 14:30 | Oncofertility Needs and Supportive Care for Breast Cancer Women in Reproductive Age: The Experience from Hope Foundation for Cancer Care in Taiwan |
Shiuyu C. Katie Lee
|
Yao-Jen Chang
|
||||
| 14:30 - 15:10 | Survivorship in Breast Cancer: Physical Activity and Alcohol Consumption and Breast Cancer |
Tristen Park
|
Liang-Chih Liu
|
||||
| 15:10 - 15:50 | Cardio-Oncology at NCKUH: Breast Cancer and Cardiotoxicity - Progress and Future Directions |
Yu-Ling Hsu
|
Chin-Sheng Hung
|